UROPLASTY INC: 10-Q filed 2013-01-24

Name: UROPLASTY INC: 10-Q filed 2013-01-24
Creator: UROPLASTY INC

What UROPLASTY INC reported in its quarterly report filed 2013-01-24 (fiscal Q3 2012): 37 published measures, 99 facts as tagged in accession 0001140361-13-003011.

This filing

Form: 10-Q (quarterly report)
Filed: 2013-01-24
Fiscal period: fiscal Q3 2012
Accession: 0001140361-13-003011 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All UROPLASTY INC filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2012-12-31	20,851,403	USD
At 2012-03-31	22,290,813	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2012-12-31	3,208,181	USD
At 2012-03-31	3,056,058	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit	Days
At 2012-12-31	17,643,222	USD
At 2012-03-31	19,234,755	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit
At 2012-12-31	4,809,541	USD
At 2012-03-31	4,653,226	USD
At 2011-12-31	5,560,570	USD
At 2011-03-31	6,063,573	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2012-10-01 to 2012-12-31	-677,324	USD	92
2012-04-01 to 2012-12-31	-2,336,205	USD	275
2011-10-01 to 2011-12-31	-1,067,538	USD	92
2011-04-01 to 2011-12-31	-3,677,332	USD	275

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2012-04-01 to 2012-12-31	-631,833	USD	275
2011-04-01 to 2011-12-31	-2,717,038	USD	275

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

Period	Value	Unit	Days
2012-04-01 to 2012-12-31	137,101	USD	275
2011-04-01 to 2011-12-31	222,826	USD	275

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

Period	Value	Unit	Days
2012-10-01 to 2012-12-31	5,590,000	USD	92
2012-04-01 to 2012-12-31	16,877,000	USD	275
2011-10-01 to 2011-12-31	5,344,000	USD	92
2011-04-01 to 2011-12-31	14,965,000	USD	275

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2012-04-01 to 2012-12-31	150,000	USD	275
2011-04-01 to 2011-12-31	208,825	USD	275

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

Period	Value	Unit	Days
2012-04-01 to 2012-12-31	644,461	USD	275
2011-04-01 to 2011-12-31	2,031,418	USD	275

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2012-12-31	-37,852,040	USD
At 2012-03-31	-35,515,835	USD

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

Period	Value	Unit	Days
2012-10-01 to 2012-12-31	12,708	USD	92
2012-04-01 to 2012-12-31	35,812	USD	275
2011-10-01 to 2011-12-31	9,352	USD	92
2011-04-01 to 2011-12-31	31,768	USD	275

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2012-12-31	1,075,259	USD
At 2012-03-31	1,171,979	USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

Period	Value	Unit	Days
2012-04-01 to 2012-12-31	608,953	USD	275
2011-04-01 to 2011-12-31	498,906	USD	275

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2012-10-01 to 2012-12-31	-677,376	USD	92
2012-04-01 to 2012-12-31	-2,332,785	USD	275
2011-10-01 to 2011-12-31	-1,061,429	USD	92
2011-04-01 to 2011-12-31	-3,677,021	USD	275

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2012-12-31	18,156,001	USD
At 2012-03-31	15,620,942	USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

Period	Value	Unit	Days
2012-10-01 to 2012-12-31	12	USD	92
2012-04-01 to 2012-12-31	12	USD	275
2011-10-01 to 2011-12-31	0	USD	92
2011-04-01 to 2011-12-31	57	USD	275

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2012-12-31	2,718,544	USD
At 2012-03-31	2,539,619	USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

Period	Value	Unit	Days
At 2012-12-31	507,183	USD
At 2012-03-31	593,585	USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

Period	Value	Unit	Days
At 2012-12-31	303,000	USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

Period	Value	Unit	Days
At 2012-12-31	2,463,572	USD
At 2012-03-31	2,704,434	USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2012-10-01 to 2012-12-31	5,533,636	USD	92
2012-04-01 to 2012-12-31	16,945,458	USD	275
2011-10-01 to 2011-12-31	5,629,079	USD	92
2011-04-01 to 2011-12-31	16,396,513	USD	275

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

Period	Value	Unit	Days
At 2012-12-31	835,153	USD
At 2012-03-31	698,742	USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

Period	Value	Unit	Days
2012-10-01 to 2012-12-31	4,856,260	USD	92
2012-04-01 to 2012-12-31	14,612,673	USD	275
2011-10-01 to 2011-12-31	4,567,650	USD	92
2011-04-01 to 2011-12-31	12,719,492	USD	275

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

Period	Value	Unit	Days
2012-10-01 to 2012-12-31	533,867	USD	92
2012-04-01 to 2012-12-31	1,695,841	USD	275
2011-10-01 to 2011-12-31	586,439	USD	92
2011-04-01 to 2011-12-31	1,499,070	USD	275

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2012-12-31	21,015,582	shares
At 2012-03-31	20,808,532	shares

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

Period	Value	Unit	Days
At 2012-12-31	-380,069	USD
At 2012-03-31	-364,165	USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

Period	Value	Unit	Days
At 2012-12-31	303,349	USD
At 2012-03-31	945,880	USD

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

Period	Value	Unit	Days
2012-10-01 to 2012-12-31	-650,281	USD	92
2012-04-01 to 2012-12-31	-2,352,109	USD	275
2011-10-01 to 2011-12-31	-1,125,094	USD	92
2011-04-01 to 2011-12-31	-3,777,627	USD	275

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

Period	Value	Unit	Days
2012-10-01 to 2012-12-31	1,058,558	USD	92
2012-04-01 to 2012-12-31	3,178,239	USD	275
2011-10-01 to 2011-12-31	924,524	USD	92
2011-04-01 to 2011-12-31	2,888,939	USD	275

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

Period	Value	Unit	Days
2012-04-01 to 2012-12-31	864,227	USD	275
2011-04-01 to 2011-12-31	832,309	USD	275

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

Period	Value	Unit	Days
2012-10-01 to 2012-12-31	215,681	USD	92
2012-04-01 to 2012-12-31	646,971	USD	275
2011-10-01 to 2011-12-31	215,164	USD	92
2011-04-01 to 2011-12-31	641,535	USD	275

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

Period	Value	Unit	Days
2012-10-01 to 2012-12-31	12,760	USD	92
2012-04-01 to 2012-12-31	32,392	USD	275
2011-10-01 to 2011-12-31	3,243	USD	92
2011-04-01 to 2011-12-31	31,457	USD	275

Deferred income tax expense or benefit

The deferred portion of income tax expense or benefit, arising from timing differences. It is not tax paid in the period.

Period	Value	Unit	Days
2012-04-01 to 2012-12-31	5,473	USD	275
2011-04-01 to 2011-12-31	-4,698	USD	275

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

Period	Value	Unit	Days
2012-04-01 to 2012-12-31	-228,768	USD	275
2011-04-01 to 2011-12-31	374,068	USD	275

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

Period	Value	Unit	Days
2012-04-01 to 2012-12-31	138,862	USD	275
2011-04-01 to 2011-12-31	146,058	USD	275

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

Period	Value	Unit	Days
2012-04-01 to 2012-12-31	-82,514	USD	275
2011-04-01 to 2011-12-31	-82,491	USD	275

Inspect the source

Entity: UROPLASTY INC / CIK 0000890846
Captured: 2026-09-22 19:32 UTC
SEC response SHA-256: 19849e6278f98a98bf135df02adb6fd292e8724ef3ceac26af63b4fe931981a9

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000890846.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))